198 related articles for article (PubMed ID: 35420133)
1. Natural killer cells act as an extrinsic barrier for in vivo reprogramming.
Melendez E; Chondronasiou D; Mosteiro L; Martínez de Villarreal J; Fernández-Alfara M; Lynch CJ; Grimm D; Real FX; Alcamí J; Climent N; Pietrocola F; Serrano M
Development; 2022 Apr; 149(8):. PubMed ID: 35420133
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the roadmap of in vivo reprogramming toward pluripotency.
Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M
Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281
[TBL] [Abstract][Full Text] [Related]
3. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
Senís E; Mosteiro L; Grimm D; Abad M
Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
[TBL] [Abstract][Full Text] [Related]
4. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.
Soufi A; Donahue G; Zaret KS
Cell; 2012 Nov; 151(5):994-1004. PubMed ID: 23159369
[TBL] [Abstract][Full Text] [Related]
5. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
[TBL] [Abstract][Full Text] [Related]
6. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.
Mah N; Wang Y; Liao MC; Prigione A; Jozefczuk J; Lichtner B; Wolfrum K; Haltmeier M; Flöttmann M; Schaefer M; Hahn A; Mrowka R; Klipp E; Andrade-Navarro MA; Adjaye J
PLoS One; 2011; 6(8):e24351. PubMed ID: 21909390
[TBL] [Abstract][Full Text] [Related]
8. Roadmap of the Early Events of
Guallar D
Cell Reprogram; 2023 Feb; 25(1):7-8. PubMed ID: 36695734
[TBL] [Abstract][Full Text] [Related]
9. Sox2 and Klf4 as the Functional Core in Pluripotency Induction without Exogenous Oct4.
An Z; Liu P; Zheng J; Si C; Li T; Chen Y; Ma T; Zhang MQ; Zhou Q; Ding S
Cell Rep; 2019 Nov; 29(7):1986-2000.e8. PubMed ID: 31722212
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
[TBL] [Abstract][Full Text] [Related]
11. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming.
Redmer T; Diecke S; Grigoryan T; Quiroga-Negreira A; Birchmeier W; Besser D
EMBO Rep; 2011 Jul; 12(7):720-6. PubMed ID: 21617704
[TBL] [Abstract][Full Text] [Related]
13. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.
Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA
Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973
[TBL] [Abstract][Full Text] [Related]
14. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
[TBL] [Abstract][Full Text] [Related]
15. Two-factor reprogramming of somatic cells to pluripotent stem cells reveals partial functional redundancy of Sox2 and Klf4.
Nemajerova A; Kim SY; Petrenko O; Moll UM
Cell Death Differ; 2012 Aug; 19(8):1268-76. PubMed ID: 22539002
[TBL] [Abstract][Full Text] [Related]
16. Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.
Soufi A; Zaret KS
Cell Cycle; 2013 May; 12(10):1487-91. PubMed ID: 23603987
[TBL] [Abstract][Full Text] [Related]
17. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
18. Efficient genetic reprogramming of unmodified somatic neural progenitors uncovers the essential requirement of Oct4 and Klf4.
Di Stefano B; Prigione A; Broccoli V
Stem Cells Dev; 2009 Jun; 18(5):707-16. PubMed ID: 18724799
[TBL] [Abstract][Full Text] [Related]
19. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate.
Yamaguchi S; Hirano K; Nagata S; Tada T
Stem Cell Res; 2011 Mar; 6(2):177-86. PubMed ID: 21130722
[TBL] [Abstract][Full Text] [Related]
20. Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming.
Hu K
Cells; 2020 Nov; 9(11):. PubMed ID: 33203179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
